Cited by 132Metabolism and Genetic DisordersNeurological diseases and metabolismGenetic and rare skin diseases.

A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency

Open access
Buchert, Rebecca, Tawamie, Hasan, Smith, Christopher, Uebe, Steffen, Innes, A. Micheil, Al Hallak, Bassam, Ekici, Arif B., Sticht, Heinrich +5 more·2014·The American Journal of Human Genetics

Abstract

Rhizomelic chondrodysplasia punctata (RCDP) is a group of disorders with overlapping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postnatal growth retardation, severe intellectual disability, and seizures. Mutations in PEX7, GNPAT, and AGPS, all involved in the plasmalogen-biosynthesis pathway, have been described in individuals with RCDP. Here, we report the identification of mutations in another gene in plasmalogen biosynthesis, fatty acyl-CoA reductase 1 (FAR1), in two families affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. Exome analyses revealed a homozygous in-frame indel mutation (c.495_507delinsT [p.Glu165_Pro169delinsAsp]) in two siblings from a consanguineous family and compound-heterozygous mutations (c.[787C>T];[1094A>G], p.[Arg263(∗)];[Asp365Gly]) in a third unrelated individual. FAR1 reduces fatty acids to their respective fatty alcohols for the plasmalogen-biosynthesis pathway. To assess the pathogenicity of the identified mutations, we transfected human embryonic kidney 293 cells with plasmids encoding FAR1 with either wild-type or mutated constructs and extracted the lipids from the cells. We screened the lipids with gas chromatography and mass spectrometry and found that all three mutations abolished the reductase activity of FAR1, given that no fatty alcohols could be detected. We also observed reduced plasmalogens in red blood cells in one individual to a range similar to that seen in individuals with RCDP, further supporting abolished FAR1 activity. We thus expand the spectrum of clinical features associated with defects in plasmalogen biosynthesis to include FAR1 deficiency as a cause of syndromic severe intellectual disability with cataracts, epilepsy, and growth retardation but without rhizomelia.

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2014.10.003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Deficiency in FAR1 causes RCDP type 4.

    “the disorder of three patients with a deficiency in FAR1, the gene coding for fatty acyl-CoA reductase 1, which generates the fatty alcohols necessary to form the ether bond of the 1-alkyl chain in ether phospholipid biosynthesis [183], was categorized as RCDP type 4 [80].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [183]

The citation lists haven’t been fetched yet

References 43 · Cited by 132

Authors
Buchert, R., Tawamie, H., Smith, C., Uebe, S., Innes, A. M., Al Hallak, B., Ekici, A. B., Sticht, H., Schwarze, B., Lamont, R. E., Parboosingh, J. S., Bernier, F. P., & Abou Jamra, R.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Calgary (CA)
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2014-11
Volume
95
Issue
5
Pages
602-610
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2070334570
Cited by
132
References
43
Citations by year
2026: 9 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 15 · 2021: 10 · 2020: 10 · 2019: 12 · 2018: 11 · 2017: 16 · 2016: 11 · 2015: 13
FWCI
9.19
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and rare skin diseases.
Keywords
rhizomelic chondrodysplasia punctata, plasmalogen biosynthesis, peroxisomal disorders, severe intellectual disability, epilepsy, congenital cataract, microcephaly, growth retardation, spasticity, consanguinity, compound heterozygosity
MeSH terms
Abnormalities, Multiple, Aldehyde Oxidoreductases, Base Sequence, Cataract, Chromatography, Gas, Deficiency Diseases, Epilepsy, Female, Genotype, Humans, Lipids, Magnetic Resonance Imaging, Male, Intellectual Disability, Models, Molecular, Molecular Sequence Data, Pedigree, Mass Spectrometry, Syndrome, Sequence Analysis, DNA, INDEL Mutation, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review